IVInessa Vorontsova

Inessa Vorontsova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Inessa Vorontsova has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Cytokine clusters in rheumatoid arthritis: pathogenetic parallels

    by A. A. Baranov, N. A. Lapkina, L. B. Shubin, I. M. Vorontsova, P. A. Chizhov, O. V. Lebedev, T. A. Buydina, E. V. Nikitina, I. A. Gorohov

    An imbalance in the production of pro- and anti-inflammatory cytokines plays a significant role in the pathogenesis of rheumatoid arthritis (RA). Seropositivity for IgM rheumatoid factor (RF) and/or antibodies to cyclic citrullinated peptides (ACCP) determines disease subtypes. The aim of the study . To conduct a cluster analysis of the profile of pro- and anti-inflammatory cytokines detected in the blood serum of RA patients with an advanced stage of the disease in comparison with healthy individuals, the presence of IgM RF and ACCP in patients. Materials and methods . The study included 154 RA patients (41 men and 113 women of middle age 56.0 [50.0; 64.0] years), disease duration 9.4 [3.0; 13.0] years), seropositive 129 (83.8 %) for IgM RF and/or 106 (68.8 %) ACCP with moderate or high (DAS 28-ESR – 5.40 [4.65; 6.00]) disease activity. Serum concentrations of interleukins (IL), tumor necrosis factor α (TNF-α), interferon-γ (INF-γ) and soluble CD 40 ligand (sCD 40L) were determined using multiplex technology. Hierarchical clustering of cytokines was performed in 20 healthy individuals and RA patients using Ward’s method. In RA, a comparison was made between seronegative and seropositive groups for IgM RF/ACCP. Results . In healthy individuals, the cytokine network exhibited a physiological organization. Cytokines were grouped into compact, well-defined modules with minimal cross-links between individual components. A dominant proinflammatory core of cytokines was absent, and a balanced cytokine network was observed. IL-4 and IL-10 formed an integral and stable part of the regulatory component. In RA, the cytokine network underwent a dramatic reorganization caused by systemic inflammation. The network architecture became significantly more complex and fragmented, with the formation of four highly stable modules. The first was composed of IL-1β and TNF-α; the second included the cytokines of the IL-17A, IL-17F, and IL-23 axis; the third included IL-6 and IFN-γ; and the fourth included IL-4, IL-10, IL-31, IL-33, and sCD 40L. Analysis of the cytokine hyperproduction diagram revealed the IL-33 cluster. In patients seronegative for IgM RF, four modules are formed. The first is formed by IL-17A, IL-23, IL-25, and IL-17F; the second by IL-1β and IFN-γ; the third includes IL-33, IL-6, and IL-10; and the fourth includes TNF-α, IL-31, sCD 40L, and IL-4. In the IgM RF-seropositive variant of RA, the network architecture became significantly more complex and fragmented. A greater number of modules were identified. The first was formed by IL-23 and IL-17F; the second by IL-1β, IL-25, and IL-17A. TNF-α was embedded in each of them. The third module included IFN-γ and IL-6, the fourth – IL-31 and sCD 40L, the fifth – IL-33 and IL-4. IL-10 is more similar to the first two. In the patient groups with and without ACCP, the component architecture was similar for both the seronegative and IgM RF-seropositive variants of the disease, with minimal differences. The most pronounced and clear differences between the compared groups were obtained when analyzing the patient groups with and without IgM RF and/or ACCP. Conclusions . The results of cluster analysis demonstrate significant differences in the cytokine network architecture in RA compared to the control group, with the identification of a distinct IL-33 cluster. Differences are also observed between seronegative and seropositive subtypes of the disease.

  • Open Access

    Dynamics of specific immune response and autoantibodies against the background of vaccination with the Gam-COVID-Vac in healthy young individuals

    by A. A. Baranov, O. P. Rechkina, M. A. Borodina, P. N. Berezin, S. S. Zolotavkina, Yu. А. Savelev, V. I. Veresh, V. I. Smirnova, E. D. Kuznetcova, I. M. Vorontsova

    Relevance. The Coronavirus 2019 (COVID-19) pandemic has affected all countries of the world and has renewed attention to the timely prevention of viral infections through specific immunization of the general population. However, some issues related to the safety of vaccine administration and the production of autoantibodies after immunization remain unclear.Objective. To evaluate the dynamics of the formation of a specific immune response to the SARS-CoV-2 virus, autoantibody production and interrelationships between them during vaccination with Gam-COVID-Vac (Sputnik V) in healthy young adults.Material and methods. The retrospective study included 45 practically healthy students who were fully vaccinated with two components of Gam-COVID-Vac at the university medical center and made 3 follow-up visits to the center. There were 32 females (71.0%) and 13 males (29.0%) aged 19 to 28 years, with a median age of 23.00 [22.00;24.00] years. All trainees were analyzed for IgG and IgM antibodies to SARS-CoV-2 in serum by enzyme-linked immunosorbent assay (ELISA) using SARS-CoV-2-IgG-IgG-IFA-BEST and SARS-CoV-2-IgM-IFA-BEST test systems, as well as IgG antibodies to double-helix deoxyribonucleic acid (anti-dsDNA) using kits (Vecto-dsDNA-IgG) of Vector-Best JSC (Russia). The concentration of IgM and IgG antibodies to cardiolipin (IgM aCL, IgG aCL) by the ELISA method (kits of ORGenTec Diagnostika, Germany) was investigated three times in 29 patients. Statistical processing of the results was performed using the generally accepted methods of parametric and nonparametric analysis.Results. In the examined individuals before vaccination with Gam-COVID-Vac, the levels of IgM SARS-CoV-2 and IgG SARS-CoV-2 were low and within the reference values. After administration of the first component of the vaccine, the level of IgM SARS-CoV-2 increased significantly compared with the period before vaccination (KP: 0.28 [0.17;1.25] u.u. and 0.07 [0.04;0.09] u.u., respectively, p 0.05). However, after the second step, the level of IgG anti-dsDNA increased and almost reached significant differences with the initial one (p=0.05). The concentration of IgG aCL increased, reaching significant differences after the second-stage vaccination compared to before (1.37 [1.02;1.51] GPL U/mL and 1.00 [0.81;1.40] GPL U/mL, respectively, p Conclusions. In men and women of young age, a specific antiviral immune response is effectively formed when vaccinated with the Gam-COVID Vac. It is more pronounced in men than in women, especially after administration of the first component of the vaccine, but is not associated with the production of certain types of autoantibodies characteristic of immunoinflammatory rheumatic diseases. In women after vaccination, in some cases there is induction of IgG anti-dsDNA or IgM aCL synthesis, but their concentration is low and transient.

  • The main pro- and antiinflammatory cytokines in rheumatoid arthritis: interrelationships and pathogenetic significance

    by N. A. Lapkina, A. A. Baranov, I. M. Vorontsova, K. M. Konovalov, P. A. Chizhov, O. V. Lebedev, T. A. Buydina

    Imbalance in the production of pro- and anti-inflammatory cytokines plays an important role in the pathogenesis of rheumatoid arthritis (RA).  The aim of the study. To determine the concentration and frequency of increase in serum of pro- and anti-inflammatory cytokines in patients with RA in the advanced stage of the disease, assessment of the relationship between them, clinical and laboratory activity of the disease and autoantibodies.   Materials and methods. We examined 154 RA patients (41 men and 113) women, of average age (56.0 [50.0; 64.0] years), disease duration (9.4 [3.0; 13.0] years), seropositive 129 (83.8 %) for IgM rheumatoid factor (RF) and/or 106 (68.8 %) antibodies to cyclic citrullinated peptides (ACCP) with moderate to high (DAS 28-ESR – 5.40 [4.65; 6.00]) disease activity. The concentration of interleukin (IL), tumor necrosis factor α (TNF-α), interferon-γ (INF-γ), soluble CD 40 ligand (sCD 40L) in serum was determined by multiplex technology.   Results. In RA patients, the concentration of IL-6, IL-23, IL-31, IL-33 and INF-γ was significantly higher, and TNF-α values were significantly lower than in controls. The levels of IL-1β, IL-17A, IL-17F, IL-25 and sCD 40L were not different from donors. IL-10 values were significantly higher than donors, and IL-4 values were not different from controls. In RA, the frequency of IL-33 elevation was 87.0 %, IL-6 51.6 %, IL-31 48.1 %, IL-17F 46.1 %, IL-23 42.9 % and INF-γ 39.0 %, IL-17A 29.9 %, IL-1β 26.6 %, TNF-α 23.4 %, IL-25 11.7 % and sCD 40L 3.2 % of patients. IL-33 hyperproduction was significantly predominant over other cytokines (p < 0.001). Elevated values of IL-10 were found in 16.2 % and IL-4 in 12.3 % of patients. Hyperproduction of proinflammatory cytokines, except IL-25 and sCD 40L, significantly prevailed over IL-4 and IL-10. Correlations of proinflammatory cytokines among themselves and with IL-4 and IL-10 were found. High values of IL-33 were associated only with IL-31. IL-4 and IL-10 concentrations were significantly correlated with each other. IL-6 concentration was found to be associated with DAS 28-ESR, CDAI and SDAI; IL-25 and sCD 40L were associated with CDAI and SDAI; IL-17A and IL-33 were associated with SDAI; IL-4 and IL-10, with CDAI and SDAI; IL-31 and IL-33, with CRP; TNF-α and INF-γ, with CRP; IL-17A, and IgM RF and ACCP; IL-31 and INF-γ, with IgM RF. IL-4 and IL10 were positively correlated with IgM RF, and IL-4 was negatively correlated with ADCP.  Conclusions. In RA patients in the advanced stage of the disease, there is an imbalance between pro- and anti-inflammatory cytokines, with a predominance of IL-33 production. Despite the presence of interrelationships between cytokines, there are significant differences between them in associations with clinical indices, laboratory indicators of disease activity and autoantibodies.


  • Potential In Vivo UVC Disinfection of Catheter Lumens: Estimation of the Doses Received by the Blood Flow Outside the Catheter Tip Hole

    by Jimmy Bak, Thomas M. Jørgensen, Jurgen Helfmann, Ute Gravemann, Inessa Vorontsova

    We have demonstrated that it is possible to launch UVC LED light into bacterial contaminated polymer tubes/catheters and disinfect the intraluminal space of these tubes. This can be achieved by UVC treatment of the catheters on a regular basis. Catheters are in the distal end equipped with an exit hole for administration of drugs, bloods or nutrients into the bloodstream. Even if the UVC light is strongly attenuated during its propagation through the catheter tube a fraction of the UVC launched into the catheter will escape through the exit hole and irradiate the blood. We demonstrate by calculations that very small effective doses are exposed to the blood (ca 10(-4) J m(-2)). This dosage level is very low compared with UVC doses reported from other therapeutic applications. The very short residence time of the blood constituents in the irradiated volume in front of the exit hole is the main reason why the UVC exposure to the blood in the catheter application is so low. The very low dose received by the blood through the catheter tip indicated that possible side effects are negligible and makes the UV disinfection technique feasible in a clinical setting.